Safety, Interactions, and Regulatory Oversight of Glaucoma Supplements

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/safety-interactions-and-regulatory-oversight-of-glaucoma-supplements

Test your visual field online: https://visualfieldtest.com

Excerpt:

Safety, Interactions, and Regulatory Oversight of Glaucoma SupplementsMany patients with glaucoma explore nutritional supplements or “nutraceuticals” hoping to protect their optic nerves or improve blood flow. However, evidence for their effectiveness is limited and conflicting, and supplements carry potential risks. Unlike prescription drugs, dietary supplements are regulated as foods: manufacturers do not need to prove safety or efficacy before marketing (). In fact, under U.S. law supplements are “assumed safe” unless shown harmful (). Thus oversight is limited and adulteration or contamination have been documented () (). Patients and clinicians should therefore approach ocular supplements with caution: they can complement glaucoma care, but cannot replace proven IOP-lowering treatments or regular eye exams (). Common Glaucoma Supplements and Their UsesMultiple supplements are promoted in glaucoma, often for their antioxidant or circulation effects. For example, Ginkgo biloba is thought to improve blood flow to the optic nerve. Magnesium is believed to relax blood vessels and enhance ocular perfusion. Melatonin (a sleep hormone) has been reported to slightly lower IOP in some studies. Various vitamins and antioxidants (e.g. vitamin C, E, A, B-complex, and anthocyanins like bilberry) are also marketed for neuroprotection. In practice, however, high-quality clinical trials are scarce. Systematic reviews emphasize that study results are mixed and inconclusive () (). For instance, one analysis found a few small trials where antioxidant supplements modestly improved IOP, but overall the evidence remains “uncertain and inconclusive” (). Another reviewer noted that results of vitamin studies were “conflicting”, leaving patients and doctors in doubt about any real benefit (). Safety Profiles and Adverse EffectsEven when supplements seem “natural,” they can have side effects or toxicity at high doses. Common adverse events include digestive upset (nausea, diarrhea) and headache. Specific examples relevant to glaucoma agents:Ginkgo biloba – Generally well-tolerated, but it inhibits platelet function. Case reports and a recent study found that Ginkgo can increase bleeding risk, especially if taken with aspirin, clopidogrel or warfarin () (). In one analysis, Ginkgo use was strongly correlated with bleeding symptoms and abnormal clotting tests (). Patients on blood-thinners should avoid Ginkgo, as it could precipitate serious hemorrhage (). Bilberry and other anthocyanins – These plant compounds have antioxidant properties, but like Ginkgo they can also affect platelets. Bilberry may potentiate antiplatelet drugs and has been linked to stomach upset, especially at high doses. (Data are sparse but caution is advised with any berry extracts in patients on anticoagulants.)Vitamin E – A popular antioxidant, high-dose vitamin E can prolong bleeding. One cohort study of patients on warfarin found that higher serum vitamin E levels independently predicted a greater bleeding risk (). In practical terms, taking extra vitamin E while on anticoagulants or heading into surgery is discouraged.Magnesium – When taken orally at moderate doses, magnesium is usually safe. However, excess magnesium acts as a smooth-muscle relaxant and lowers blood pressure (). In one trial of hypertensive patients, 300 mg Mg daily significantly reduced systolic and diastolic BP (). Very high magnesium (or impaired kidney clearance) can precipitate hypotension, dizziness and muscle